Avalo Therapeutics, Inc. (AVTX)

NASDAQ: AVTX · Real-Time Price · USD

18.05

-0.20 (-1.10%)

Aug 3, 2026, 4:00 PM EDT - Market closed

Avalo Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	955	336	78	7	48	192
Market Cap Growth	1018.15%	332.09%	966.44%	-84.65%	-75.21%	-3.16%
Enterprise Value	873.23	237.86	-56.74	-0.12	53.77	169.99
Last Close Price	18.05	18.16	7.43	9.10	1209.60	4896.00

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	16184.73	5698.16	176.43	3.79	2.63	35.52
PB Ratio	6.51	4.05	0.58	1.00	-4.35	8.31
P/TBV Ratio	4.93	3.36	0.46	-	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	14800.58	4031.45	-128.66	-0.06	2.98	31.49
EV/EBITDA Ratio	-	-	0.83	0.00	-	-
EV/EBIT Ratio	-	-	0.83	0.00	-	-
EV/FCF Ratio	-	-	1.16	0.00	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	-	0	0	0	-1.78	1.42
Net Debt / Equity Ratio	-1.20	-1.18	-1.01	-1.01	-0.57	-0.94
Net Debt / EBITDA Ratio	1.04	1.36	1.97	0.27	-0.17	0.27
Net Debt / FCF Ratio	1.37	1.91	2.74	0.24	-0.23	0.31
Asset Turnover	-	0.00	0.01	0.07	0.32	0.09
Inventory Turnover	-	-	-	128.40	118.41	72.73
Quick Ratio	7.07	7.60	19.33	1.64	0.68	2.99
Current Ratio	7.66	8.14	19.96	1.82	0.74	3.11
Return on Equity (ROE)	-111.97%	-72.43%	-50.06%	1747.11%	-684.77%	-354.08%
Return on Assets (ROA)	-73.32%	-54.70%	-80.05%	-100.67%	-65.97%	-132.20%
Return on Invested Capital (ROIC)	-	-	-	-491.17%	-595.49%	-2350.31%
Return on Capital Employed (ROCE)	-82.54%	-58.98%	-85.56%	-198.00%	-104.61%	-184.87%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Buyback Yield / Dilution	-131.03%	-78.82%	-2599.19%	-608.45%	-	-
Total Shareholder Return	-131.03%	-78.82%	-2599.19%	-608.45%	-	-

SEC Filings: 10-K · 10-Q